(NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older ...

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large ...

In a report released on July 6, Joanne Wuensch from Citi reiterated a Buy rating on Dexcom, with a price target of $84.00. The company’s shares closed yesterday at $72.38. 55% O ...

Check the settings on Apple Watch, Galaxy Watch, Pixel Watch, Huawei Watch, and Garmin that can affect glucose alerts, ...

Eightco Holdings Inc. ("Eightco" or the "Company") today provided an update on its total holdings, highlighting its position ...

BTB Real Estate Investment Trust ("BTB" or the "REIT") announces today that the monthly cash distribution for the month of July 2026 is $0.025 per unit, representing $0.30 per unit on an annualized ...

Insulet Corporation PODD has commercially launched its Omnipod 5 Automated Insulin Delivery (AID) system and the Omnipod ...

DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...

Influencers have found their latest wellness obsession — and, once again, diabetics got there first. First, came GLP-1 drugs.

Adults in the US who want to measure their blood glucose levels using a wearable sensor will soon be able to buy one over-the-counter (OTC) for the first time. The FDA has cleared Dexcom’s Stelo as ...

Positive findings from a phase 2 trial were followed by disappointing news; however, new guidelines aim to help clinicians ...